Literature DB >> 2068029

Prevalence of anticardiolipin antibodies in the elderly British population.

K K Chakravarty1, R E Gray, M Webley, M A Byron, J Wozniak.   

Abstract

In a cross-sectional study of 100 healthy elderly individuals, anticardiolipin antibodies (aCL) were measured using an ELISA technique. aCL were not detected in the majority of subjects (63%), and in the remaining 37% titres were within the laboratory reference range (mean +5 standard deviations) previously determined for adults of all ages. In contrast, significant titres of IgM rheumatoid factor were found in 10%, antimitochondrial antibody in 13%, antinuclear factor in 5%, anti-smooth muscle antibody in 18%, antiparietal cell antibody in 10%, and antireticulin antibody in 1%. Antibodies to single or double-stranded DNA were not detected in any subject. We conclude that, although other auto-antibodies may be present in the healthy aging population in Britain, abnormally elevated levels of aCL antibody do not occur, and when present may be an indicator of autoimmune-mediated pathology.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068029      PMCID: PMC2398833          DOI: 10.1136/pgmj.67.786.358

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  23 in total

Review 1.  An immune mechanism in thrombosis.

Authors:  G R Hughes
Journal:  Q J Med       Date:  1988-10

Review 2.  Anti-phospholipid antibodies.

Authors:  E N Harris; A E Gharavi; G R Hughes
Journal:  Clin Rheum Dis       Date:  1985-12

3.  The Prosser-White oration 1983. Connective tissue disease and the skin.

Authors:  G R Hughes
Journal:  Clin Exp Dermatol       Date:  1984-11       Impact factor: 3.470

4.  Anticardiolipin antibodies: occurrence in Behçet's syndrome.

Authors:  R G Hull; E N Harris; A E Gharavi; A Tincani; R A Asherson; G Valesini; A M Denman; G Froude; G R Hughes
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

5.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

6.  Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.

Authors:  S Loizou; J D McCrea; A C Rudge; R Reynolds; C C Boyle; E N Harris
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

7.  Cerebral infarction in systemic lupus: association with anticardiolipin antibodies.

Authors:  E N Harris; A E Gharavi; R A Asherson; M L Boey; G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1984 Jan-Mar       Impact factor: 4.473

8.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

Authors:  E N Harris; A E Gharavi; M L Boey; B M Patel; C G Mackworth-Young; S Loizou; G R Hughes
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

9.  Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.

Authors:  H I Glueck; K S Kant; M A Weiss; V E Pollak; M A Miller; M Coots
Journal:  Arch Intern Med       Date:  1985-08

10.  Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases.

Authors:  D A Gastineau; F J Kazmier; W L Nichols; E J Bowie
Journal:  Am J Hematol       Date:  1985-07       Impact factor: 10.047

View more
  1 in total

1.  The prevalence of autoantibodies in an elderly sub-Saharan African population.

Authors:  R Njemini; I Meyers; C Demanet; J Smitz; M Sosso; T Mets
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.